ABOUT KAVON CLINREG

Founded in 2018

Kavon ClinReg was built to fill a growing gap in the clinical development world—boutique, high-touch regulatory and clinical support tailored to early-stage biotech. We specialize in delivering quality outcomes through strategy-first thinking and deeply personalized service. When you're navigating high-stakes trials with limited margin for error, you need experience you can trust and agility you can count on.

OUR
MISSION

Our mission is to streamline clinical and regulatory pathways by providing expert guidance, strategic insight, and hands-on support to life sciences companies —helping them navigate complexity, reduce timelines, and achieve regulatory and clinical success with confidence, accelerating the R&D pipeline.

About the Founders

DEBRA A. V. NOVAK
Co-Founder & CEO

Debra “Vigi” Novak brings over 30 years of global leadership and project execution to Kavon ClinReg. With experience managing over 1,000 events and complex initiatives, she ensures every program runs with precision, accountability and momentum. Her expertise strengthens Kavon’s mission to streamline clinical and regulatory pathways for biotech innovators.

STEPHEN M. NOVAK, MS, MA
Co-Founder & COO

Stephen Novak brings over 30 years of global leadership expertise to Kavon ClinReg. A retired US Army Intelligence Officer and seasoned biotech strategist, he has led successful FDA and EMA approvals, built high-performing teams, and driven growth across commercial programs worldwide. His strategic insight powers Kavon’s mission to accelerate clinical development and regulatory success for emerging biotech companies.

OUR
VISION

Our vision is to redefine clinical and regulatory excellence by becoming the most trusted and agile partner in accelerating life sciences innovation, empowering companies to bring safe, effective therapies to patients faster.